Amanote Research

Amanote Research

    RegisterSign In

Dulaglutide Slows Kidney Disease in Type 2 Diabetes

The Lancet - United Kingdom
doi 10.1016/s0140-6736(19)32550-4
Full Text
Open PDF
Abstract

Available in full text

Categories
Medicine
Date

February 1, 2020

Authors
Nestor Oliva-DamasoElena Oliva-DamasoJuan PayanEsteban Porrini
Publisher

Elsevier BV


Related search

Dulaglutide Slows Kidney Disease in Type 2 Diabetes − Author's Reply

The Lancet
Medicine
2020English

Dulaglutide – New in the Treatment of Type 2 Diabetes

Effective Pharmacotherapy
2019English

Dulaglutide: Third Once-Weekly GLP-1 Agonist for Type 2 Diabetes

Pharmacy Today
2014English

Metformin in Patients With Type 2 Diabetes and Kidney Disease

JAMA - Journal of the American Medical Association
Medicine
2014English

Management of Type 2 Diabetes Mellitus in Chronic Kidney Disease

Current Medical Research and Opinion
Medicine
2014English

Economic Burden of Moderate Chronic Kidney Disease in Type 2 Diabetes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

New England Journal of Medicine
Medicine
2010English

Association of Hypothyroidism in Type 2 Diabetes Mellitus and Diabetic Kidney Disease

2020English

Inсretin-Based Therapy in Patients With Type 2 Diabetes and Chronic Kidney Disease

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy